The Dose Curves
Guidelines give you the minimum. The dose-response curves show the shape — how much of the benefit arrives in the first hundred minutes a week, where the aerobic curve flattens, and why the strength curve turns back down after its peak. This page reads both curves honestly, including what a pooled cohort average can never tell you about your own week.
What the evidence supports
- The WHO 2020 guidelines set the population floor: 150–300 minutes per week of moderate aerobic activity, or 75–150 minutes of vigorous activity, plus muscle-strengthening activity on two or more days (Bull et al., Br J Sports Med, 2020).
- Muscle-strengthening activity shows a J-shaped dose-response: benefit peaks around 30–60 minutes per week and weakens at higher volumes, past roughly 140 minutes weekly (Momma et al., 2022).
- Aerobic dose-response curves in large cohorts fall steeply at low weekly volumes and flatten across the upper range — the tenth hundred minutes buy far less than the first.
- In a 416,420-adult cohort, the lowest mortality was associated with meeting both the aerobic and the muscle-strengthening guidelines rather than topping either one alone (Coleman et al., 2022).
What remains uncertain
- The two curves are not measured on one common scale — aerobic exposure is minutes, strength exposure is usually days or sessions — so comparing their shapes is approximate.
- Population averages hide how much individual response varies with age, training history, and health status.
- The far right of both curves is poorly characterized; few cohorts contain enough very-high-volume participants to describe the high-dose tail reliably.
Evidence last reviewed: October 7, 2026. Conclusions may change as new research is published.
Start with the Floors, Not the Peaks
The WHO numbers are deliberately unglamorous: 150 to 300 minutes a week of moderate aerobic activity (or half the time at vigorous intensity), plus strength work on two or more days (Bull et al., 2020). These are population floors — the dose that moved the largest number of people in the guidance modeling, weighted toward the vast majority who start sedentary. A floor is not an optimum, and exceeding it is not heroic; it is simply a different part of the curve.
Worth knowing how such floors are built: guidance committees weigh dose-response modeling, cohort evidence, and feasibility for the widest population. The result is a number chosen so that most people can clear it — not a number at which benefits stop.
The other reason to respect the floors: whichever curve you read, the steepest part sits at the bottom. Going from nothing to something is where the association moves most; going from good to great is where it flattens. That single fact does more for how you should spend a tight week than any peak value on this page.
The Strength Curve Is J-Shaped
The strength dose-response in the Momma et al. (2022) meta-analysis has a distinctive shape: benefit rises with weekly muscle-strengthening activity up to a peak around 30–60 minutes per week, then flattens and eventually turns back toward weaker associations past roughly 140 minutes weekly. A J-shape, not a straight line — more is not monotonically better.
Two honest footnotes. First, strength exposure in cohorts is usually counted as sessions or days, so "30–60 minutes" is a rough translation of a session count. Second, the shape itself may partly reflect who trains at high volume rather than any harm from the training — heavy strength work can cluster with other characteristics that confound the far right of the curve. The J-shape is real in the data; its interpretation is not settled.
The Aerobic Curve Flattens, It Doesn't Fall
The aerobic picture is different in an important way: across large cohorts, mortality associations improve steeply from inactivity to moderate volumes, keep improving gently toward the guideline range, and then flatten. What the general-population data do not show is a reliable reversal at high volumes — the curve's problem is diminishing returns, not punishment.
The exception worth keeping separate: very-high-volume endurance athletes are a self-selected subset, and studies of them answer a different question about extreme exposure. For the rest of us, the practical read is simple — aerobic dose is forgiving, and the marginal minute matters less as the total grows. Vigorous intensity compresses the timeline; the WHO exchange treats one vigorous minute as roughly equivalent to two moderate ones (Bull et al., 2020).
Where the Two Shapes Differ
- 🕐 Minutes do not mean the same thing. Aerobic minutes are usually continuous movement; strength minutes are fractions of sessions, and two or three sessions of 20–30 minutes already sit near the peak of the strength curve.
- 📅 Frequency is the strength currency. The strength dose is specified in days per week (two or more) because recovery between sessions is part of the dose; aerobic dose is specified in weekly totals, and bouts of any length now count.
- 📐 Intensity has an exchange rate only on the aerobic side. Moderate and vigorous minutes trade at roughly two to one; the strength literature has no comparable public exchange, which is why the guideline simply says "two or more days."
- 🧱 Both curves are steepest at the start. Beginner gains — fitness, strength, metabolic markers — come fastest; moving from nothing to the floor is the single largest change available on either curve.
The Dose Cheat-Sheet
Everything above collapses into four rows. "Observed peak" describes where cohort associations are strongest, not where effort must go. The parent topic places these doses into a full week:
| Mode | Guideline floor | Observed association peak | Curve shape |
|---|---|---|---|
| 🏃 Moderate aerobic | 150–300 min/week | Benefit keeps accumulating, flattening near the top of the range | Flattening |
| 💨 Vigorous aerobic | 75–150 min/week | Comparable to the moderate range, fewer minutes | Flattening |
| 🏋️ Muscle-strengthening | 2+ days/week | 30–60 min/week; attenuating past ~140 | J-shaped |
| 🧮 Combined | Both floors together | Lowest mortality when both are met (Coleman 2022) | Additive |
Guidelines Are Floors, Not Personal Optima
A guideline is an average of a distribution, not a target ringed in gold. Some people will need more than the floor to hit a given fitness checkpoint; some will get more out of the same minutes at a different intensity. That is why the individual side of dose lives in response checkpoints rather than universal numbers — the personal-signal territory that the hidden vital signs topic covers. How the floors fold into one sustainable week is the job of the 3-2-1 formula.
How to Use the Curves Without Overfitting Them
Practical rules that survive contact with the data: clear the floors before optimizing the peaks. For strength, the sweet spot around 30–60 minutes a week means two or three normal sessions — while chasing the far right of a J-shaped curve is not obviously rewarded. For aerobic activity, extend duration before adding complexity once the floor is routine, because the flattening curve forgives a missed week far more than a missed month.
And when the curves disagree with your experience — you add minutes and feel worse, or lift more and stop recovering — believe your own checkpoints over someone else's average. Averages describe populations; your week is a sample of one. When the two curves seem to conflict in your week — strength volume high, aerobic thin — restore the floor first: the steep section at the bottom is the part both shapes agree on.
Questions, Answered Briefly
- 🏋️ Can I hit the strength peak in two sessions? Usually yes — two or three sessions of 20–30 minutes land inside the 30–60 minute weekly window where the association peaks.
- 🏃 Is more than 300 aerobic minutes worth it? The curve is flat there, so extra minutes are not clearly rewarded for mortality outcomes — though they may serve performance or other goals.
- 🚶 Does the aerobic floor have to be structured exercise? No — the guideline counts any moderate-intensity movement, and walking is the delivery vehicle most of the cohort evidence rests on.
- 📅 What if I miss a week entirely? The curves are long-run associations, not weekly contracts. Resume at the floor; the flattening shape means consistency across months matters more than perfection within any seven days.
📐 A curve is a population statement
Every number on this page is an average over thousands of people whose weeks, bodies, and histories differ from yours. The curves are excellent for one job — showing where more dose stops buying much, and where the strength curve actually turns down — and useless for another: predicting exactly what a given change will do for you. Use them for direction and magnitude, then check the response against your own markers.
The Bottom Line
- Clear the floors first — 150–300 moderate aerobic minutes (or half the time vigorous) plus two days of strength work captures the steep part of both curves (Bull et al., 2020).
- The strength curve is J-shaped — benefit peaks around 30–60 minutes a week and weakens at high volumes; more is not monotonically better (Momma et al., 2022).
- The aerobic curve flattens, it doesn't fall — diminishing returns, not damage, is what the general-population data show.
- Averages are not prescriptions — use the curves for direction, then let your own checkpoints arbitrate the details.
Related Topics
- Bull FC et al., "World Health Organization 2020 guidelines on physical activity and sedentary behaviour," British Journal of Sports Medicine (2020)
- Momma H et al., "Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies," British Journal of Sports Medicine (2022)
- Coleman CJ et al., "Dose-response association of aerobic and muscle-strengthening physical activity with mortality: a national cohort study of 416,420 US adults," British Journal of Sports Medicine (2022)
- Garber CE et al., "Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults," Medicine & Science in Sports & Exercise (2011)